Practice Update - ESC Congress 2017
ISSN 2208-150X (Print) ISSN 2208-1518 (Online)
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2017 26–30 AUGUST 2017 • BARCELONA, SPAIN
THE BEST OF ESC 2017 The Interleukin-1β Inhibitor Canakinumab Cuts Cardiovascular Disease and Lung Cancer Risk by Reducing Inflammation – CANTOS Trial • Renal Denervation Lowers Blood Pressure in Hypertensive Patients Not Taking Antihypertensive Medication – SPYRAL HTN-OFF MED Trial • Catheter Ablation Improves Outcomes in Patients With Heart Failure and Atrial Fibrillation – CASTLE-AF Trial • Two Results of the PURE Study May Be Game Changers in Heart Disease Prevention
This ESC Congress 2017 PracticeUpdate Conference Series is distributed with the support of A. Menarini Australia.
Made with FlippingBook - Online Brochure Maker